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Chondroitin sulfate proteoglycans display both inhibitory and stimulatory effects on cell adhesion and neurite outgrowth
in vitro. The functional activity of these proteoglycans appears to be context specific and dependent on the presence of
different chondroitin sulfate-binding molecules. Little is known about the role of chondroitin sulfate proteoglycans in the
growth and guidance of axons in vivo. To address this question, we examined the effects of exogenous soluble chondroitin
sulfates on the growth and guidance of axons arising from a subpopulation of neurons in the vertebrate brain which express
NOC-2, a novel glycoform of the neural cell adhesion molecule N-CAM. Intact brains of stage 28 Xenopus embryos were
unilaterally exposed to medium containing soluble exogenous chondroitin sulfates. When exposed to chondroitin sulfate,
NOC-21 axons within the tract of the postoptic commissure failed to follow their normal trajectory across the ventral
midline via the ventral commissure in the midbrain. Instead, these axons either stalled or grew into the dorsal midbrain or
continued growing longitudinally within the ventral longitudinal tract. These findings suggest that chondroitin sulfate
proteoglycans indirectly modulate the growth and guidance of a subpopulation of forebrain axons by regulating either
matrix-bound or cell surface cues at specific choice points within the developing vertebrate brain. © 1998 Academic Press
Key Words: chondroitin sulfate proteoglycans; axon tract; axon guidance; neuronal pathfinding; neural cell adhesion
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INTRODUCTION
Cell–substrate interactions play an important role in the
growth and guidance of axons within the peripheral nervous
system. In particular, the extracellular matrix molecule
laminin is a strong promoter of axon growth, and its
distribution in peripheral tissues provides both a conducive
and a stimulatory substrate for growing axons. In addition
to laminin, other extracellular matrix components such as
proteoglycans, glycoproteins, and growth factors also pro-
mote axon growth. Some of these molecules are inhibitory
for axon growth and are likely to be involved in steering and
guiding growth cones by repelling axons from inappropriate
territories. Chondroitin sulfate proteoglycans are typically
thought of as chemorepulsive molecules that provide bar-
riers to axon growth. In vitro studies have demonstrated
that substrate-bound chondroitin sulfate proteoglycans in-
hibit neurite outgrowth, even on otherwise permissive
substrates (Snow et al., 1990; Freidlander et al., 1994;
Yamada et al., 1997). In vivo, chondroitin sulfate proteogly-
cans are often localized to sites avoided by growing axons.
For instance, chondroitin sulfate proteoglycans are present
in the periphery of the retina, in areas that are inhibitory to
retinal axon growth (Brittis et al., 1995). Chondroitin sul-
fate proteoglycans are localized within the posterior scle-
rotome, which is chemorepulsive to sensory axons (Keynes
and Stern, 1984; Snow et al., 1990; Oakley and Tosney,
1991; Perris et al., 1991) as well as in the cortical plate at a
time when thalamic afferents accumulate in the underlying
subplate region (Emerling and Lander, 1996). Thalamic
afferents only enter the cortical plate as levels of chon-
droitin sulfate proteoglycans fall in the deeper cortical
layers (Emerling and Lander, 1994).
More than a dozen different chondroitin sulfate proteo-
glycans have been identified within the developing and
adult brain (Herndon and Lander, 1990). Three abundant
brain-specific chondroitin sulfate proteoglycans, phospha-
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can, neurocan, and brevican, appear to have distinct roles in
modulating cell–cell and cell–matrix interactions. Phos-
phacan is a mRNA splice variant of the extracellular
domain of a receptor-type protein-tyrosine phosphatase and
binds to the cell adhesion molecules, N-CAM, L1, and
TAG-1 (Milev et al., 1994; Milev et al., 1996). Phosphacan
binding to TAG-1 depends largely upon the presence of its
chondroitin sulfate chains since soluble chondroitin sulfate
is an effective inhibitor of phosphacan–TAG-1 interactions
(Milev et al., 1996). Neurocan is a developmentally regu-
lated brain-specific chondroitin sulfate proteoglycan that
binds both N-CAM and L1 via mechanisms partially depen-
dent upon chondroitin sulfate side chains (Friedlander et
al., 1994; Milev et al., 1994). Brevican is another abundant
chondroitin sulfate proteoglycan present as both soluble
and membrane-bound forms in the nervous system.
Substrate-bound brevican is antiadhesive for neurons and
also inhibits neurite outgrowth, effects that are dependent
on the presence of chondroitin sulfate chains (Yamada et
al., 1997). However, not all axons respond equally to chon-
droitin sulfate proteoglycans; different types of neurons
exhibit varying levels of sensitivity to these proteoglycans.
Growth cones from retinal ganglion neurons grow on con-
centrations of chondroitin sulfate that are much higher
than that which inhibits the growth of dorsal root ganglion
and forebrain axons (Snow and Letourneau, 1992). Low
levels of a brain-derived chondroitin sulfate proteoglycan
can actually promote rather than inhibit neurite outgrowth
from neocortical neurons (Iijima et al., 1991). During devel-
opment of thalamocortical projections, thalamic axons ini-
tially grow through the subplate, a region rich in chon-
droitin sulfate proteoglycans. In vitro assays revealed that
the chondroitin sulfates present in the subplate are stimu-
latory for both neuronal adhesion and neurite outgrowth
(Emerling and Lander, 1996). The adjacent cortical plate
also contains chondroitin sulfate proteoglycans; however,
these chondroitin sulfates are inhibitory to both neuronal
adhesion and neurite outgrowth. This dichotomy in action
of chondroitin sulfates was attributed to the differential
expression of chondroitin sulfate-binding molecules, rather
than to differences in the types of chondroitin sulfate
proteoglycans, since excess soluble chondroitin sulfates
neutralized both inhibitory and stimulatory effects in the
developing cortex (Emerling and Lander, 1996). Thus, chon-
droitin sulfates may act either by directly modulating
adhesive interactions or by indirectly organizing matrix-
and cell-bound cues.
Although chondroitin sulfate proteoglycans affect neurite
outgrowth in vitro, very little is understood about the role
of these molecules in the growth and guidance of axons in
vivo. Recent studies have revealed that pioneer axons
within the embryonic Xenopus brain navigate along stereo-
typical pathways and establish an early scaffold of axon
tracts which acts as a template for subsequent axon growth
(Easter and Taylor, 1989; Taylor, 1991). In the present
study, we examined the role of chondroitin sulfates during
development of the initial scaffold of axon tracts. Confocal
microscopy was used to examine the trajectory of axons
within Xenopus brain preparations exposed to exogenous
soluble chondroitin sulfates. We report here that chon-
droitin sulfates selectively perturb the growth of a subpopu-
lation of embryonic forebrain axons as they cross the
ventral midline within the midbrain.
METHODS
Antibodies
The mouse monoclonal antibody against acetylated a-tubulin
was obtained from ICN Biochemicals Inc. (Costa Mesa, CA). The
mouse monoclonal antibody against NOC-2 was purchased from
the Commonwealth Serum Laboratories (Victoria, Australia). The
mouse monoclonal antibody CS-56 against 4- and 6-sulfated chon-
droitin sulfates was obtained from Sigma Chemical Company (St.
Louis, MO).
Immunohistochemistry
The immunostaining of whole mount Xenopus brains was
performed as previously described (Anderson and Key, 1996). Stage
32 Xenopus embryos were fixed by immersion in 4% paraformal-
dehyde and brains were dissected and dehydrated in a graded
ethanol series (70 to 100%). Embryos were then washed in ethanol:
propylene oxide, followed by two consecutive washes in 100%
propylene oxide, and rehydrated through a graded ethanol series
(100 to 70%) to Tris-buffered saline (TBS; 0.1 M, pH 7.4). Brains
were then incubated for 1 h in 2% bovine serum albumin (BSA) and
0.3% Triton X-100 to block nonspecific binding and reacted with
either the acetylated a-tubulin or the NOC-2 antibodies in 2% BSA
in TBS. Embryos were then reacted with either biotinylated goat
anti-mouse IgM (m-chain specific) or biotinylated goat anti-mouse
IgG (g-chain specific) secondary antibodies (Sigma Chemical Co.)
and visualized using either Extravidin–FITC or –TRITC (Sigma
Chemical Co.).
For double-label analysis, embryos were first incubated with the
acetylated a-tubulin antibody and then visualized using Extra-
vidin–FITC (Sigma Chemical Co.; 60 mg/ml) as described above.
Embryos were then incubated with the NOC-2 antibody followed
by a TRITC-conjugated goat anti-mouse IgM secondary antibody
(Jackson Immunoresearch Laboratories Inc., West Grove, PA).
Control embryos, reacted with either one of the primary antibodies
and with both secondary antibodies, revealed no cross-reactivity of
secondary antibodies. Some fixed Xenopus brains were snap frozen
and 14-mm-thick sections cut using a cryostat. These sections were
immunostained as described above.
Serial images of brain whole mounts (up to a depth of 50 mm)
were collected on a Bio-Rad 1024 scanning confocal microscope
and assembled into a single montage. Color images were assembled
using both Photoshop 4.0 (Abode Systems Incorporated, San Jose,
CA) and Coreldraw 7.0 (Corel Corporation Limited, Dublin, Ire-
land). Images were printed using a Kodak XLS-8300 dye sublima-
tion printer.
Exposed Xenopus Brain Preparation
Exposed brain experiments were performed as previously de-
scribed with slight modifications (Chien et al., 1993). All surgeries
were carried out in 100% modified Ringers (MMR): 100 mM NaCl,
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2 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, 0.4 mg/ml
tricaine methanosulfonate, 1% Fungibact, 50 mg/ml gentamicin
sulfate, 10 mg/ml phenol red (pH 7.4). Stage 28 embryos were
immobilized by pinning in a Sylgard petri dish and the epidermis
and eye were removed from the left side of the head. Embryos were
transferred to experimental solution or control solution (80%
MMR) and allowed to develop until stage 32 (4–6 h) when they
were fixed in 4% paraformaldehyde. Experimental medium con-
tained a 50:50 mixture of chondroitin 6-sulfate and chondroitin
4-sulfate (Sigma Chemical Co.; 10 mg/ml 5 ;20 mM) while
control medium contained either the unrelated disaccharides lac-
tose (20 mM) or N-acetyl-lactosamine (10 mM) or BSA (fraction V,
Fisher Scientific, Houston, TX; 10 mg/ml).
RESULTS
Chondroitin Sulfates Are Expressed in the
Embryonic Xenopus Brain
The localization of chondroitin sulfates containing 4- and
6-sulfates was examined in the embryonic Xenopus brain
by immunostaining coronal sections with the monoclonal
antibody CS-56 (Avunar and Geiger, 1985). Weak immuno-
reactivity for chondroitin sulfates was present throughout
the neuroepithelium, while strong staining was observed at
the outer surface of the brain (Fig. 1A). In order to determine
whether the chondroitin sulfates at the apical surface were
associated with developing axon tracts we double labeled
sections with CS-56 and a monoclonal antibody against
acetylated a-tubulin, a marker for growing axons (Fig. 1B).
This analysis revealed that chondroitin sulfates appeared to
be highly concentrated in the extracellular matrix outside
the brain rather than in the outer marginal zone which
contains the axon tracts. Control sections exhibited negli-
gible background staining. Thus, chondroitin sulfates were
diffusely distributed throughout the depth of the brain
neuroepithelium in both the marginal and the ventricular
zones.
Chondroitin Sulfates Direct Axon Guidance across
the Ventral Midline in the Midbrain
Previous studies have suggested that chondroitin sul-
fates, even when diffusely distributed, can have an indirect
role in axon growth by modulating interactions between
axons and guidance cues (Emerling and Lander, 1996). In
order to test the role of chondroitin sulfates in the forma-
tion of axon tracts we developed a method for preparing
whole mounts of embryonic Xenopus brain between stages
28 and 32. Our previous studies have revealed that the
retinotectal pathway develops normally in exposed brain
preparations between stages 34 and 40 (McFarlane et al.,
1995; Walz et al., 1997). However, the effect of exposing
Xenopus brains on the growth and formation of other axon
tracts at younger ages has not been examined. Thus, in
preliminary experiments we analyzed the patterning of
axon tracts following unilateral exposure of embryonic
Xenopus brains between stages 28 and 32. Exposed brain
preparations were bathed in medium containing either the
disaccharides lactose (20 mM) or N-acetyl-lactosamine (10
mM) or the nonglycosylated protein BSA (10 mg/ml). Fol-
lowing the culture period, exposed brain preparations were
fixed and immunostained for the axonal marker acetylated
a-tubulin, and whole mounts were viewed by confocal
microscopy. Scans of the lateral surface of the brain were
compiled and three-dimensional-like images of axon tracts
were constructed. This approach provided a qualitative
assessment of the effects of the culture conditions on the
trajectories of axon tracts. These preliminary analyses re-
vealed that the development of the principal axon tracts and
commissures was unaffected by unilateral exposure in
young embryos. At stage 32, the overall topography of axon
tracts within exposed brain preparations (Fig. 1C) was
typical of normal unexposed stage 32 brains (not shown). At
this stage the Xenopus brain consists of a simple scaffold of
axons with five principal axon tracts (two longitudinal and
three vertical tracts) and four commissures. Figure 2 is a
schematic diagram of the rostral brain showing the major
pathways of axons. The principal longitudinal tract of the
forebrain is the tract of the postoptic commissure (TPOC)
that follows the longitudinal axis of the brain as it curves
around the cephalic flexure. In the tegmentum of the
midbrain the TPOC merges with the ventral longitudinal
tract (VLT). Three vertically oriented tracts have axons that
merge with the TPOC: (i) the supraoptic tract (SOT) which
arises from the presumptive telencephalic nucleus; (ii) the
dorsodiencephalic tract (DVDT) which arises from the
epiphysis; and (iii) the tract of the posterior commissure
(TPC) which arises from a dorsal nucleus. There are four
principal commissures: the anterior and postoptic commis-
sures which cross the midline to join the contralateral
nucleus and TPOC, respectively; the ventral commissure
which contains a subpopulation of axons from the TPOC;
and the posterior commissure which contains axons from
the nucleus of the TPC.
We next tested the role of chondroitin sulfates on axon
tract development by bathing exposed Xenopus brains be-
tween stages 28 and 32 in medium supplemented with
exogenous soluble chondroitin sulfates, lactose, or BSA. At
stage 28, growing axons are present in all tracts and com-
missures of the forebrain except for the supraoptic tract. No
overall difference was observed in the basic framework of
axon tracts as judged by antiacetylated a-tubulin staining,
after exposing brains to lactose, BSA (Fig. 1C), or chon-
droitin sulfates (Figs. 1D and 1E). However, in the presence
of chondroitin sulfate, slight disruptions were consistently
observed in the distribution of axons within the rostral
midbrain (arrowheads, Figs. 1D and 1E). Axons at the
junction point between the TPOC, VLT, and ventral com-
missure (VC) in chondroitin sulfate-exposed brains ap-
peared to be more diffusely organized than in control
preparations (arrowheads, Fig. 1C). The TPOC consists of a
heterogenous population of axons that arise from diverse
origins including the nucleus of the posterior commissure,
the epiphysis, nucleus of the presumptive telencephalon,
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FIG. 1. Immunostaining of coronal sections (A, B) and whole mounts (C–E) of stage 32 embryonic Xenopus brains. The section in A and
B was double labeled for CS-56 (chondroitin sulfates containing 4- and 6-sulfates) and acetylated a-tubulin (depicts all axons). (A)
Chondroitin sulfates are diffusely distributed throughout the wall of the neuroepithelium in the midbrain. Strong immunofluorescence is
observed at the surface of the brain (arrows). (B) Double exposure for chondroitin sulfates in red and acetylated a-tubulin in green. Open
arrows, the TPOC which is joined across the ventral midline by the VC. The strong chondroitin sulfate immunofluorescence appears to be
external to the axon tracts. Embryonic brain preparations were exposed to either control medium (C) or to medium supplemented with
soluble chondroitin sulfates (D–E) between stages 26 and 32. Animals were then fixed and brains imaged via confocal microscopy for
acetylated a-tubulin. Control brains (C) revealed a normal distribution of axons tracts. Brains exposed to chondroitin sulfates also contained
a normal complement of axon tracts; however, the trajectory of axons in the midbrain appeared more diffuse and disorganized at the
junction of the TPOC, TPC, and VC (between arrowheads) in comparison to normal brains (arrowheads in C). C.S., chondroitin sulfates;
DVDT, dorsoventral diencephalic tract; nPT, nucleus of presumptive telencephalon; POC, postoptic commissure; MZ, marginal zone; SOT,
supraoptic tract; TPC, tract of the posterior commissure; TPOC, tract of the postoptic commissure; V, ventricle; VC, ventral commissure;
VLT, ventral longitudinal tract; VZ, ventricular zone. Scale bar, 200 mm (C–E) and 80 mm (A and B).
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and the nucleus of the TPOC. The TPOC forms at stage 25
(;29.5 h postfertilization) from axons arising from the
ipsilateral nucleus of the TPOC and is joined by axons
arising from the contralateral nucleus of the presumptive
telencephalon at stage 28 (;32.5 h postfertilization; Taylor,
1991). Because immunostaining for acetylated a-tubulin
reveals all axons in this tract including those that have
pioneered the TPOC before Xenopus brains are exposed at
stage 28, it was difficult to assess any effect of chondroitin
sulfates on axon pathfinding in these preparations. To
circumvent this problem, we next immunostained brains
with an antibody against NOC-2, a novel glycoform of the
neural cell adhesion molecule (Anderson and Key, unpub-
lished observations) and specifically examined the trajec-
tory of these axons in more detail. The projection of
NOC-21 axons (Fig. 3A) is identical to that previously
described for another subpopulation of axons expressing
NOC-1 (Anderson and Key, 1996). We have examined
NOC-21 axons because the immunostaining of these axons
is much stronger and more specific than that observed with
NOC-1 staining. NOC-21 axons arise from the nucleus of
the presumptive telencephalon and cross the midline via
the postoptic commissure to enter the contralateral TPOC.
These axons begin to navigate along the TPOC just as we
start to expose the brains at stage 28 to chondroitin sulfates.
Thus, by specifically examining NOC-21 axons we were
able to resolve the behavior of a discrete subpopulation of
TPOC axons that arise from a single origin in the nucleus of
the presumptive telencephalon. Moreover, because these
axons are actively growing along the TPOC during the
exposure period it enabled us to selectively examine the
effect of chondroitin sulfates on axon pathfinding.
NOC-21 axons course caudally within the TPOC and
either cross the ventral midline in the VC to join the
contralateral TPOC or instead continue growing caudally
and enter the VLT. The trajectory of NOC-21 axons in
exposed brain preparations (Fig. 3A) was identical to that
observed in normal animals in vivo (not shown). Thus,
exposing the brains did not alter pathfinding by this defined
subpopulation of growing axons. However, brains exposed
to exogenous chondroitin sulfates demonstrated highly
selective defects in the trajectories of NOC-21 axons (Fig.
3B). Aberrant growth was confined to axons coursing within
the TPOC, particularly at the level of its junction with the
VC. NOC-21 axons often failed to turn and grow into the
VC (open arrows, Figs. 3B and 3D–3F). Only 21% of em-
bryos cultured in the presence of chondroitin sulfates
(n 5 24) had NOC-21 axons that entered the VC (Fig. 4).
This diversion of axons from the VC could account for the
diffuse nature of axon trajectories observed at the
TPOC–VC junction in those brains immunostained for
acetylated a-tubulin (Figs. 1D and 1E). Contrary to what
was observed in brains exposed to chondroitin sulfates,
100% of control brains cultured in either lactose (n 5 5) or
BSA (n 5 15) contained a normal complement of NOC-21
axons in the VC (Figs. 3C and 4). Brains double labeled for
both acetylated a-tubulin and NOC-2 clearly revealed that
NOC-21 axons entered the VC in control cultures (Fig. 3G).
However, NOC-21 axons typically failed to negotiate the
ventral turn into the VC and instead continued growing
longitudinally into the VLT in brains exposed to chon-
droitin sulfates (Fig. 3H). It should be noted that axons are
present in the VC (Fig. 3H) since this commissure forms
before the brains are cultured. Interestingly, 30% of brains
exposed to chondroitin sulfates also contained axons that
exited the TPOC inappropriately and projected dorsally
(arrows, Figs. 3B, 3E, 3F, and 4) and in some cases axons also
prematurely turned ventrally (arrowhead, Fig. 3F). This
phenotype was never observed in control cultures (Figs. 3C
and 4). The trajectory of NOC-21 axons within the postop-
tic commissure and VLT was unaffected by the presence of
exogenous chondroitin sulfate in the culture medium. The
exogenous chondroitin sulfates selectively affected the
growth of NOC-21 axons as they extended along the TPOC
and navigated through the TPOC–VC junction. These ef-
fects were therefore highly specific and not a generic
response of axons to the presence of exogenous molecules
in the culture medium.
FIG. 2. Schematic representation of axon tracts on the lateral
surface of stage 32 embryonic Xenopus rostral brain (diencephalon
and midbrain). At this stage the rostral end of the neural tube is
curved about the cephalic flexure (c.f.). The dorsal surface of the
diencephalon contains the epiphysis (Epi.). Although the eye
vesicle is not drawn, the position of the optic stalk (o.s.) is
represented. The telencephalon is not present at this age but it will
emerge from the site of the presumptive telencephalic nucleus
(nPT). Axons arising from this nucleus form the supraoptic tract
(SOT) and contribute to the tract of the postoptic commissure
(TPOC) as well as the anterior (AC) and postoptic (POC) commis-
sures. The TPOC courses along the ventrolateral surface of the
brain and at the level of the midbrain forms the ventral longitudi-
nal tract (VLT). Axons exit the TPOC at the diencephalon–
midbrain border to form the ventral commissure (VC). The epiphy-
sis gives rise to the dorsoventral diencephalic tract (DVDT) that
merges with the TPOC. Slightly caudal to the DVDT is the tract of
the posterior commissure (TPC) which also fasciculates with the
TPOC. The posterior commissure arises from the dorsal midbrain
and crosses the midline to join the contralateral TPC.
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DISCUSSION
There are numerous molecules that have specific binding
sites for glycoaminoglycans in proteoglycans (Hileman et
al., 1998). Soluble exogenous glycoaminoglycans can inter-
act with these sites and disrupt development by compe-
tively inhibiting binding of native proteoglycans. Our re-
sults demonstrate that exogenous chondroitin sulfates
selectively interfere with the guidance of a specific popula-
tion of axons in the embryonic Xenopus brain. Exposure of
intact embryonic Xenopus brain to exogenous soluble chon-
droitin sulfates allowed us to examine axons as they navi-
gated in an otherwise “in vivo-like” environment. While
the overall topography of axon tracts appeared to be unaf-
fected by exogenous chondroitin sulfates, the growth of a
subpopulation of forebrain axons was selectively disrupted.
These axons normally extend along the TPOC and then
turn into the VC at the forebrain–midbrain border. In the
presence of exogenous chondroitin sulfates two principal
defects in axon guidance were observed: first, some axons
prematurely exited the TPOC and extended dorsally into
the diencephalon or midbrain; and second, axons failed to
turn ventrally and enter the VC at the forebrain–midbrain
border. These results highlight the differential responsive-
ness of growing axons to exogenous chondroitin sulfates
during axon tract formation within the embryonic verte-
brate brain.
The trajectory of axons navigating the TPOC and VC was
revealed by immunostaining for NOC-2, a novel glycoform
of the neural cell adhesion molecule. Although many
TPOC axons that do not express NOC-2 appear unaffected
by the presence of chondroitin sulfates, they pioneer this
pathway and cross the ventral midline in the VC prior to
the beginning of the culture period. In contrast, NOC-21
axons are actively growing and navigating along these
pathways during the period in which the brains were
exposed to exogenous chondroitin sulfates. Although
NOC-2 immunostaining provides a convenient means of
assessing the effects of chondroitin sulfates on axons in the
TPOC and at the TPOC–VC junction, it is possible that
other subpopulations of axons may react differently. We
have recently shown that the TPOC consists of mixed axon
populations expressing either NOC-1 or NOC-2 alone or
FIG. 3. Confocal microscopy of NOC-21 axon tracts on the exposed lateral surface of embryonic Xenopus brain preparations. (A–F)
Immunostained with NOC-2 antibodies; (G–H) double labeled with antibodies against NOC-2 (red fluorescence) and acetylated a-tubulin (green
fluorescence). The NOC-21 axons in double-labeled preparations appear yellow. (A) Brain preparation exposed to unsupplemented medium
exhibited a normal topography of NOC-21 axons in the rostral brain. NOC-21 axons arose from the nucleus of the presumptive telencephalon
(nPT) and either crossed the midline in the postoptic commissure (POC) or grew ventrally within the supraoptic tract (SOT) and entered the
ipsilateral tract of the postoptic commissure (TPOC). In the rostral midbrain, NOC-21 axons in the TPOC either turned ventrally into the ventral
commissure (VC) or continued growing caudally within the ventral longitudinal tract (VLT). (B, D–F) Brain preparations exposed to medium
supplemented with chondroitin sulfates. (B) The overall topography of NOC-21 axons appears similar to that observed in control animals;
however, some axons have exited the TPOC and turned dorsally into inappropriate regions (filled arrows). No NOC-21 axons entered the VC
(open arrows), although they continued growing into the VLT as in controls. (C) High magnification of TPOC-VC junction of a control animal
clearly demonstrates the presence of NOC-21 axons in the VC. (D–F) Examples of three different brains exposed to chondroitin sulfates. No
NOC-21 axons enter the VC (open arrows) while some NOC-21 axons are observed to inappropriately exit the TPOC and grow into the dorsal
forebrain (filled arrows). (F) An axon inappropriately exits the TPOC and enters the ventral brain rostral to the VC. (G, H) High magnification of
double-labeled brain preparations at the junction of the TPOC and VC. (G) NOC-21 axons (arrow) enter the VC and cross the ventral midline of
the rostral midbrain in control brain preparations. (H) In the presence of chondroitin sulfates, NOC-21 axons fail to enter the VC despite the
presence of a well formed commissure (asterisk). NOC-21 axons (arrow) continue to enter the VLT. Scale bar, 100 mm (A and B) and 50 mm (C–H).
FIG. 4. Effect of exposing Xenopus brains to exogenous chondroitin
sulfates. Graph shows the percentage of animals that have NOC-21
axons either in the VC or in the dorsal diencephalon. It is normal for
NOC-21 axons to cross in the VC and hence 100% of control animals
exhibited this phenotype. It is not normal for NOC-21 axons to exit
the TPOC and grow into the dorsal diencephalon and hence no axons
in control animals exhibited this phenotype.
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together (unpublished observations). Thus, it remains to be
determined whether these other subpopulations react simi-
larly to exogenous chondroitin sulfates. NOC-21 axons
arise from the nucleus of the presumptive telencephalon
and course ventrally via the postoptic commissure and
enter the TPOC. The growth of NOC-21 axons along this
rostral pathway was unaffected by exogenous chondroitin
sulfates. Axons only exhibited aberrant trajectories as they
grew within the TPOC. Some axons were observed to exit
the TPOC and extend dorsally into inappropriate territo-
ries. However, only a small proportion of NOC-21 axons in
30% of cultured embryos exhibited such behavior, which
indicated that chondroitin sulfates had a minimal role in
controlling the longitudinal growth of axons in the TPOC.
By far the most notable effect of chondroitin sulfates on
axon guidance was observed at the forebrain–midbrain
border where axons normally turn ventrally and cross the
midline in the VC. In 79% of cultured embryos, NOC-21
axons failed to enter the VC in the presence of exogenous
chondroitin sulfate, indicating that these molecules have
an important role in neuronal pathfinding at the TPOC–VC
junction. It should be noted that although we used 20 mM
chondroitin sulfates in the culture medium we did not
assess the concentration of sugars that penetrated the
neural tube. Preliminary evidence indicates that exogenous
chondroitin sulfates penetrate only the exposed half of the
neural tube in the region of elongating axons (Walz and
Holt, unpublished observations). In our culture studies we
used a mixture of chondroitin 4-sulfate and chondroitin
6-sulfate in order to more closely reflect the variously
sulfated sugars that are present in native chondroitin sul-
fate proteoglycans. Further studies are needed to determine
which sugar species and chondroitin sulfate proteoglycans
are responsible for perturbed axon guidance.
Exogenous glycoaminoglycans also affect the guidance of
a subpopulation of growing axons in cultures of cockroach
embryos (Wang and Denburg, 1992). Heparin and heparan
sulfate, and not chondroitin sulfates, selectively perturbed
the growth of axons in two of the six axon tracts, indicating
that specific heparin-binding sites were mediating axon
guidance. Soluble heparan sulfates affect retinotectal path-
finding in the embryonic Xenopus midbrain, probably by
interacting with native FGF-2 (Walz et al., 1997). Numer-
ous studies indicate that soluble chondroitin sulfates pro-
mote neurite outgrowth in vitro (Lafont et al., 1992;
Fernaud-Espinosa et al., 1994; Challacombe and Elam,
1997). Although the mode of action of soluble chondroitin
sulfates in these studies is not known, it is possible that
they either facilitate neurotrophic effects of endogenous
factors or alternatively bind to receptors and mimick the
action of chondroitin sulfate proteoglycans. Our results
show that axon elongation is neither inhibited nor pro-
moted in vivo and that axon navigation is clearly perturbed
at specific sites in developing axon tracts in Xenopus.
Immunostaining revealed that native proteoglycans con-
taining either chondroitin 4-sulfate or chondroitin 6-sulfate
are widely expressed in the Xenopus brain and do not
delineate channels, pathways, or specific choice points.
How then do chondroitin sulfates selectively regulate the
guidance of a subpopulation of forebrain axons as they
extend along the TPOC and turn into the VC? It seems
likely that exogenous chondroitin sulfates are interfering
with specific guidance cues for axons within this pathway.
Chondroitin sulfates in proteoglycans can modulate adhe-
sive interactions mediated by several neural cell adhesion
molecules, some of which may be involved in axon guid-
ance at the forebrain–midbrain border. For example, neuro-
can, a 500-kDa brain-derived chondroitin sulfate proteogly-
can, inhibits neuronal adhesion and neurite growth (Rauch
et al., 1992; Friedlander et al., 1994). The binding of
neurocan to the neural cell adhesion molecules N-CAM
and Ng-CAM can be inhibited by the addition of free
chondroitin sulfate (Friedlander et al., 1994). Thus, native
chondroitin sulfate proteoglycans may be modulating the
activity of specific adhesion molecules that act as guidance
cues and are distributed along the pathway of the TPOC and
VC. Another possibility is that exogenous soluble chon-
droitin sulfates may be mediating their effects by directly
interfering with guidance mediated by the NOC-2 N-CAM
glycoform. However, this seems unlikely since we observe
a completely different phenotype when NOC-2 function is
inhibited with blocking antibodies (Anderson and Key,
unpublished observations). Alternatively, chondroitin sul-
fates may bind diffusible soluble tropic molecules and these
bound ligands may provide localized guidance cues for
axons in the TPOC. Interestingly, chondroitin sulfates bind
to the soluble chemotropic factor netrin-1 (Litwack et al.,
1995) which is expressed by cells underlying the TPOC and
at the forebrain–midbrain border (de la Torre et al., 1997). It
is tempting to speculate that the soluble exogenous chon-
droitin sulfates added to the brain cultures in the present
study affected axon guidance by competing off bound
netrin-1 from native chondroitin sulfate proteoglycans.
This is consistent with our recent evidence that DCC, a
netrin-1 receptor, plays a role in the growth of axons across
the midline in the VC (Anderson and Key, unpublished
observations).
In conclusion, we postulate that chondroitin sulfate-
binding molecules (either cell adhesion molecules or diffus-
ible guidance cues) provide navigational cues to forebrain
axons as they extend along the TPOC and then turn
ventrally into the VC. Directional growth is probably
achieved through the differential expression of chondroitin
sulfate-binding molecules and not chondroitin sulfate pro-
teoglycans, which are diffusely distributed in embryonic
Xenopus brain. Our results support the presence of multiple
cues for axon growth along the TPOC; however, chon-
droitin sulfate-binding molecules appear to have a major
role in directing axons to exit the TPOC and turn into the
VC. The molecular cues that interact with chondroitin
sulfates and are responsible for neuronal pathfinding at the
TPOC–VC junction remain to be determined.
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